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Summary Serum samples taken between 6 and 20 weeks of gestation were obtained from 28 mothers who
gave birth to cryptorchid sons (cases) and from 108 control mothers. In comparison with controls the cases had
10% higher geometric mean oestradiol (95% CI - 13% to +39%: P= 0.42) and 10% lower geometric mean
testosterone (95% CI -27% to + 10%: P=0.30). Among the samples collected between 6 and 14 weeks of
gestation geometric mean concentrations of oestradiol and testosterone were 5% lower (95% CI -32% to
+31%: P=0.74) and 25% lower (95% CI -45% to +1%: P=0.06) respectively in cases than in controls.
Among the samples collected between 15 and 20 weeks of gestation geometric mean concentrations of
oestradiol and testosterone were 29% higher (95% CI -8% to +79%: P=0.14) and 21% higher (95% CI
-8% to +60%: P=0.18) respectively in cases than in controls. The results do not support the hypothesis that
cryptorchidism may be caused by high concentrations of oestradiol in the maternal blood during the first phase
of testicular descent, but suggest that the possible association ofcryptorchidism with low maternal testosterone
during early gestation should be further investigated.
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A survey conducted between 1984 and 1988 found that
cryptorchidism occurs in 1.55% of boys examined at 3
months of age (John Radcliffe Hospital Cryptorchidism
Study Group, 1992). This rate is almost double that found
in a comparable survey conducted in the late 1950s (Scorer,
1956). Cryptorchidism is an important condition because it is
associated with an increased risk oftesticular cancer (Chilvers
and Pike, 1992; United Kingdom Testicular Cancer Study
Group, 1994) and with infertility (Chilvers et al., 1986). The
aetiology of cryptorchidism is unknown, but it may involve
abnormalities of the hormonal control of testicular descent.
The testes descend as far as the internal inguinal ring before
15 weeks of gestation, but further descent into the scrotum
does not occur until the third trimester. On the basis of
clinical and experimental studies Hutson (1985) has suggested
that the first phase of descent is probably stimulated by
mullerian inhibiting substance and the second by testoster-
one, both secreted by the foetal testes. In mice injections of
oestradiol or diethylstilboestrol into the mother prevent the
first phase of descent, probably by blocking production of
mullerian inhibiting substance and by causing atrophy of the
gubernaculum, while injection of the antiandrogen cyproter-
one acetate prevents the second phase of descent (Hutson,
1985; Walker et al., 1990). Clinical and epidemiological
studies have suggested that exposure to diethylstilboestrol
during pregnancy increases the risk of cryptorchidism in man
(Depue, 1984). Henderson et al. (1979) suggested that
cryptorchidism might also be associated with high levels of
endogenous oestradiol in the maternal circulation; in two
small case - control studies designed to test this hypothesis,
neither Burton et al. (1987) nor Bernstein et al. (1988) found
an association of cryptorchidism with high maternal total
oestradiol in early pregnancy, but the latter authors did
report a higher average percentage of bioavailable oestradiol
in the mothers of cases. Bernstein et al. (1988) also measured
testosterone, and found similar testosterone concentrations in
mothers of cases and controls, but in a comparison of
hormone concentrations in normal pregnancies in black and
white women this group found 48% higher testosterone in
the blacks than in the whites and suggested that these high
levels of testosterone might explain the low rates of
cryptorchidism and of testis cancer in blacks (Henderson et
al., 1988).
In this paper we report oestradiol and testosterone
concentrations in early pregnancy serum from mothers of
cryptorchid sons (cases) and controls. Results are given for
all blood samples collected between 6 and 20 weeks of
gestation, but the primary hypothesis was that mothers of
cryptorchid sons might have high levels of oestradiol during
weeks 6 to 14, the period encompassing the first phase of
testicular descent. We also describe the relationships of
maternal oestradiol and testosterone with parity, cigarette
smoking and other possible risk factors for cryptorchidism.
Subjects and methods
Subjects
The subjects were a subset of participants in a questionnaire-
based case - control study of cryptorchidism in Oxfordshire.
Cases and controls were identified from a cohort of 7500
boys examined shortly after birth by specially trained
research nurses (John Radcliffe Hospital Cryptorchidism
Study Group, 1992).
Cryptorchidism at birth was defined by position (John
Radcliffe Hospital Cryptorchidism Study Group, 1988). All
boys with cryptorchidism at birth were re-examined at 3
months of age, since in approximately 70% of boys who are
cryptorchid at birth the testes descend spontaneously by 3
months of age (John Radcliffe Hospital Cryptorchidism
Study Group, 1992). For the current study, only boys who
were cryptorchid both at birth and at 3 months were accepted
as cases. Controls were chosen from among mothers of boys
who had normal testicular descent at birth, using stratified
sampling to ensure that there were sufficient numbers of
controls in the lower birthweight categories: random selection
of 7% ofmothers with sons of birthweight >2500 g; random
selection of 20% of mothers with sons of birthweight 2000-
2499 g; and selection of all mothers with sons of birthweight
<2000 g. Mothers were not eligible if they were education-
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ally subnormal, non-English-speaking or mentally ill, or if
their sons were to be adopted or had chromosomal or other
major congenital abnormalities, or ifthey gave birth to twins.
Mothers of cryptorchid sons (cases) and controls were
interviewed 3 months after the birth of their sons; for babies
born before 40 weeks interviews were conducted 3 months
after the date on which gestation would have reached 40
weeks. A structured questionnaire was used to collect
information on the mother's age, prepregnancy weight,
height, date of last menstrual period preceding the relevant
pregnancy, smoking habit during pregnancy and social class.
Mothers were excluded from the study reported here if they
could not give a date of last menstrual period preceding
pregnancy because they had been using oral contraceptives or
had had irregular periods.
In the complete questionnaire-based case - control study
interviews were completed for 100 out of 101 eligible cases
(99%) and for 378 out of 427 eligible controls (89%). Of
these subjects, 43 cases and 206 controls were interviewed
during the period of serum collection (see below); six cases
and 53 controls were not eligible for hormone assays because
they did not have a date of last menstrual period, leaving 37
cases and 153 controls eligible for the assays.
Serum
Blood for rubella screening is collected routinely during early
pregnancy. This is done over quite a wide range of
gestational ages, tending to be earlier if taken by general
practitioners (often around 12 weeks' gestation) than if taken
in hospital (usually around 16 weeks' gestation). After testing
for rubella, serum samples are stored at -40°C for 1 year in
the Virology Laboratory at the John Radcliffe Hospital,
Oxford. This made it possible for us to collect serum samples
from the freezer for participants in the case - control study.
Serum samples taken between May 1986 and September 1988
from participants in the questionnaire-based case - control
study were collected and stored at -20°C until analysis
during 1990.
Of 37 cases and 153 controls eligible for the serum assays,
adequate serum samples were recovered from the freezer for
32 (86%) and 117 (76%) respectively. It was decided to
include subjects in the study if the serum had been collected
between 6 and 20 weeks (inclusive) after the date of the last
menstrual period; two samples for controls were collected
before 6 weeks' gestation, while four samples from cases and
seven samples from controls were collected after 20 weeks'
gestation, leaving 28 case samples and 108 control samples
for analysis.
Assays
Oestradiol concentrations were measured in duplicate by
radioimmunoassay following extraction into diethyl ether,
using Clinical Assays specific antiserum (Elstar, Wokingham,
UK) and '211-labelled oestradiol (Code IM135, Amersham
International, Amersham, UK). Dextran-coated charcoal was
used to separate free from bound steroid. The intra- and
interassay coefficients of variation were both less than 10%.
Testosterone concentrations were measured in duplicate by
radioimmunoassay following extraction into ether, using a
STRIA kit (Supra-Regional Assay Service Laboratory,
Department of Chemical Pathology, St Thomas' Hospital,
London, UK). The intra- and interassay coefficients of
variation were 10% and 12% respectively.
The serum collected for rubella testing is routinely heated
at 60°C for 20 min. This treatment would not be expected to
affect the oestradiol or testosterone molecules themselves,
but could affect the assay by affecting other components of
the serum. To reduce the likelihood of this occurring we
extracted the steroids into diethyl ether before radio-
immunoassay. We also tested the effect of heating the
serum on the oestradiol assay by dividing ten fresh samples
of pregnancy serum into two aliquots each, heat treating one
aliquot of each pair, and then measuring oestradiol in all 20
samples in one assay batch. Mean oestradiol was 1.2%
higher in the samples that had been heat treated than in the
unheated samples (paired t-test, P=0.82). Groom et al.
(1986) also concluded that heat treatment (56°C for at least
30 min) did not have an important effect on steroid assays
incorporating an extraction step: mean ratios (heated-
unheated) were 1.01, 0.92 and 0.99 for low-concentration
oestradiol, high-concentration oestradiol and testosterone
respectively.
Measurements of testosterone concentration were made
for all 28 cases and 108 controls. The volume of serum
remaining was inadequate to complete the oestradiol assay
for six subjects (three cases, three controls).
Statistical analysis
The SPSS package was used for all statistical analyses. The
oestradiol and testosterone values were logarithmically
transformed to achieve approximately normal distributions,
and the transformed values were used in all statistical
analyses. The mean values presented for oestradiol and
testosterone are geometric means. Log oestradiol values
increased with week of gestation in an approximately linear
fashion, therefore the mean oestradiol values presented were
adjusted for week of gestation as a linear variable. Log
testosterone values were not significantly correlated with
week of gestation, therefore no adjustments of mean
testosterone values for this variable were made. Since
controls were chosen by stratified sampling within three
birthweight categories, all geometric mean hormone concen-
trations were adjusted for birthweight category using two
indicator variables. (Repeating the analyses without adjusting
for birthweight caused very little change in the results
reported.) Differences between means were tested, and
adjustments for co-variates made, using analysis of co-
variance. Two-sided P-values are quoted.
The ratio of the mean hormone concentration in cases
relative to controls, and its 95% confidence interval (CI), was
calculated as the antilogarithm of the difference between the
means of the log values.
Results
Questionnaire information in cases and controls
The characteristics of cases and controls are shown in the
first part of Table I (these data are not adjusted for
birthweight). The mean age of the cases was 2.3 years
greater than that of the controls (P=0.05). Differences
between cases and controls in prepregnancy weight,
Quetelet's index, weeks of gestation at sampling and at
birth, birthweight of baby and social class were small and
were not statistically significant. Fewer cases than controls
smoked during pregnancy (P=0.05).
Hormone concentrations in cases and controls
Geometric mean oestradiol, adjusted for birthweight and
week of gestation, was 10% higher in cases than in controls
(95% CI -13% to +39%: P=0.42: Table I). In samples
collected from 6 to 14 weeks cases had a 5% lower geometric
mean oestradiol (95% CI -32% to +31%: P=0.74),
whereas in samples collected from 15 to 20 weeks cases had
a 29% higher geometric mean oestradiol (95% CI -8% to
+79%: P=0.14).
Adjusted geometric mean testosterone was 10% lower in
cases than controls (95% CI -27% to + 10%: P=0.30). In
the early gestation samples the cases had 25% lower
geometric mean testosterone (95% CI -45% to + 1%:
P=0.06), whereas in samples collected at 15 to 20 weeks
cases had 21% higher geometric mean testosterone (95% CI
-8% to +60%: P=0.18).
The results were not substantially altered by adjusting for
age as well as birthweight (and week of gestation for
oestradiol; results not shown).Cryptorchidism and maternal hormones
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Table I Relevant characteristics and hormone concentrations for mothers of cryptorchid sons (cases) and for control mothers
Variable Cases n Controls n pa
Relevant characteristics, mean (s.d.) or
percentage
Age (years) 30.1 (5.9) 28 27.8 (5.3) 108 0.05
Prepregnancy weight (kg) 61.5 (11.1) 28 61.4 (10.4) 107 0.95
Quetelet's indexb (kg m-2) 23.0 (4.3) 28 22.7 (3.5) 107 0.62
Weeks of gestation at sampling 13.7 (2.5) 28 13.9 (3.3) 108 0.83
Weeks of gestation at birth 39.8 (1.6) 28 39.2 (2.5) 108 0.28 Birthweight of baby (g) 3456 (595) 28 3379 (683) 108 0.59 First pregnancy 29% 31% 0.84 Smoking during pregnancy 14% 33% 0.05 Social class
I and II 25% 33% 0.33
III 68% 53%
IV and V 7% 14%
Geometric mean hormone concentrations (95% confidence interval)
Oestradiolc nmol 1-1
Serum 6 - 20 weeks 10.1 (8.2 - 12.5) 25 9.2 (8.3 - 10.2) 105 0.42
Serum 6 - 14 weeks 6.5 (4.9 - 8.6) 18 6.9 (5.9 - 8.1) 54 0.74
Serum 15 - 20 weeks 17.5 (13.0 - 23.7) 7 13.6 (12.2 - 15.3) 51 0.14 Testosteroned nmol 1-l 4.3
Serum 6 - 20 weeks 3.7 (3.5 - 5.1) 28 4.8 (4.3 - 5.2) 108 0.30
Serum 6 - 14 weeks 5.5 (2.9 - 4.8) 18 5.0 (4.3 - 5.7) 56 0.06
Serum 15 - 20 weeks (4.3 - 7.1) 10 4.5 (4.1 - 5.1) 52 0.18
a Two-sided test for difference between means, or chi-squared test for difference in proportions. b Calculated using prepregnancy weight. c
Adjusted for birthweight and week ofgestation. d Adjusted forbirthweight.
Hormone concentrations in controls in relation to other (1987) reported lower mean oestradiol in cases than controls
variables both in the first 100 days of pregnancy (mean in cases 30% lower) and at all gestational ages (mean in cases 29%
Neither log oestradiol nor log testosterone at 6-20 weeks' lower), but neither of these differences was statistically
gestation was significantly correlated with age or Quetelet's significant. Bernstein et al. (1988) reported almost no
index (Table II). Geometric mean oestradiol was 22% higher difference between cases and controls in geometric mean
in first than in subsequent pregnancies, 7% lower in smokers serum concentrations of oestradiol at 46-93 days' gestation
than in non-smokers and 17% lower in women in social (cases 2% higher). Thus no study has yet supported the
classes IV and V than in women in social classes I and II. hypothesis that high maternal total oestradiol is a cause of
Geometric mean testosterone was 20% higher in first than in cryptorchidism. Bernstein et al. (1988) reported a signifi-
subsequent pregnancies, 2% lower in smokers than non- cantly higher percentage of free oestradiol in cases (20%
smokers and 11% higher in women in social classes IV and V higher). We were unable to measure the percentages of free
than in women in social classes I and II. None of these steroids because heat treatment of serum denatures sex
differences was statistically significant. hormone binding globulin.
The only other study that has measured testosterone is
that of Bernstein et al. (1988). They found almost no
Discussion difference between cases and controls in testosterone at 46-
93 days' gestation (mean in cases 1% lower), in contrast to
We found no significant difference in serum oestradiol the 25% lower mean concentration in cases reported here in
concentrations between cases and controls. Burton et al. samples at 6-14 weeks' gestation. Considering both studies
Table H Relationships of hormone concentrations at 6-20 weeks' gestation with other variables in control mothers
Variable Oestradiol n pa Testosterone n Pa
Partial correlationb Partial correlationc Age (years) -0.10 105 0.33 -0.10 108 0.29 Quetelet's indexd(kg m-2) -0.01 105 0.91 0.04 107 0.71
Geometric meane Geometric meanf Parity
First pregnancy 10.7 (8.9 - 12.8) 33 0.09 5.4 (4.6 - 6.3) 33 0.07 Subsequent pregnancies 8.8 (7.8 - 10.0) 72 4.5 (4.0 - 5.0) 75 Cigarette smoking
Non-smoker 9.6 (8.5 10.8) 72 0.53 4.8 (4.3 - 5.3) 72 0.89 Current smoker 8.9 (7.4 10.7) 33 4.7 (4.0 - 5.5) 36 Social class
I and II 11.0 (9.3 13.1) 36 0.07 4.6 (3.8 - 5.6) 36 0.74 III 8.5 (7.4 9.7) 54 4.8 (4.2 - 5.4) 57 IV and V 9.1 (7.0 -11.8) 15 5.1 (4.0 -6.5) 15
Two-sided test for significance of partial correlation coefficient or of difference between means (analysis of co-variance).
b Adjusted for birthweight and week ofgestation, correlation with log of hormone concentration. cAdjusted for birthweight, correlation with log ofhormone concentration. d Calculated using prepregnancy weight. e nmol1-l (95% confidence interval), adjusted for birthweight and week of gestation. fnmol -1(95% confidenceinterval), adjusted for birthweight.Cryptorchidism and maternal hormones
TJA Key et a!
701
the evidence that low maternal testosterone concentrations in
early pregnancy are associated with a higher risk for
cryptorchidism is therefore weak.
Henderson et al. (1988) noted that the incidence of
cryptorchidism is three times higher in white males than in
black males, and that testis cancer is rare in black males.
They compared hormone concentrations in pregnant black
and white women who gave birth to normal babies and
reported that geometric mean testosterone was significantly
lower in white than in black women (by 32%). These findings
are consistent with the hypothesis that high maternal levels of
testosterone may produce the low risk of cryptorchidism in
blacks, but other differences between blacks and whites might
be responsible.
Both oestradiol and testosterone were non-significantly
higher in first compared with subsequent pregnancies.
Bernstein et al. (1986) reported in a longitudinal study that
oestradiol was higher in first than in second pregnancies, and
the difference was larger and statistically significant for free
oestradiol. Bernstein et al. (1986) suggested that the higher
oestradiol levels in first pregnancies could be responsible for
the higher risk of cryptorchidism associated with sons being
firstborn in some studies, but our results suggest the
possibility that any such tendency might be counteracted by
higher testosterone levels in first pregnancy.
Bernstein et al. (1989) reported that oestradiol during early
pregnancy was 18% lower in smokers than in non-smokers;
human chorionic gonadotrophin and sex hormone binding
globulin were also lower in smokers. In the current study
geometric mean oestradiol was only 7% lower in smokers
than in non-smokers, and there was no difference between
these groups in testosterone. Although we found substantially
fewer smokers among cases than among controls, the
difference in the complete case-control study population is
much less (29% of case mothers and 33% of control mothers
were smokers, C Chilvers, personal communication).
We examined the relationship between hormone concen-
trations and social class because of the higher risk associated
with lower social class in the complete case - control study
(C Chilvers, personal communication). No significant
associations were found, but the lower oestradiol and higher
testosterone in mothers in social classes IV and V compared
with mothers in social classes I and II is the reverse of what
might be expected if the risk associated with low social class
is hormonally mediated.
In conclusion, this study does not support the hypothesis
that cryptorchidism may be caused by high concentrations of
oestradiol in the maternal blood during early gestation. The
results suggest that the possible association of cryptorchidism
with low maternal testosterone during early gestation should
be further investigated.
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